Advicenne announces the results of its capital increase with preferential subscription rights

02.10.2023 - Regulatory News: This press release must not be distributed directly or indirectly in the United States, Canada, Australia, or Japan. Advicenne (Euronext Growth - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and ...

Related Keywords

France ,United States ,United Kingdom ,Canada ,Australia ,Paris ,France General ,French ,Advicenne Euronext ,Bpifrance Investissement ,Philippe Boucheron ,Catherine Dunand ,Lang Schwarz ,Didier Laurens ,European Parliament ,Board Of Directors The Company ,Deputy Chief Biotech ,Cemag Invest ,Capital Increase ,Chief Executive Officer ,New Shares ,French Commercial ,Euronext Growth ,Combined General Meeting ,French Monetary ,Financial Code ,General Regulations ,Des March ,Investor Relations ,Marketing Approval ,Euronext Paris ,Euronext Growth Paris ,European Economic Area ,Member State ,Prospectus Regulation ,Securities Act ,Advicenne Stock ,